Genetic Analysis AS (XSAT:GEAN)
0.5300
0.00 (0.00%)
At close: Sep 30, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 38.11 million as of October 6, 2026. Its market cap has decreased by -35.05% in one year.
Market Cap
38.11M
Enterprise Value
31.13M
Revenue
19.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
ChartMarket Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 38.11M, a decrease of -83.82%. That is a compound annual growth rate of -30.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 38.11M | -13.94% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lightning Group AB | 53.17M |
| QBNK Holding AB | 52.17M |
| OurLiving AB | 45.63M |
| Kontigo Care AB | 44.59M |
| Touchtech AB | 44.34M |
| Beyond Frames Entertainment AB | 41.74M |
| Gomero Group AB | 36.46M |
| Vidhance AB | 27.47M |